ATG5 and neoplasm: Sox2OT‐V7 can promote autophagy of tumour cells through the Sox2OT‐V7/miR‐22‐3p/ULK1 axis and Sox2OT‐V7/miR‐142‐5p/ULK1, ATG4A and ATG5 axis, mediating drug resistance to DOX.31